Association of TNFAIP3 With Immune-mediated TTP

Abroad (travel likely)Recruiting

Conditions

Thrombotic Thrombocytopenic Purpura, Acquired

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy
Contact: Study coordinator (Ilaria Mancini, PhD) · ilaria.mancini@guest.unimi.it · +390255035414
Contact: Principal Investigator (Ilaria Mancini, PhD)
Andrea Artoni, MD, PhD (Sub-investigator)

Study leads

Ilaria Mancini, PhD
Principal Investigator
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Daratumumab in Immune-mediated Thrombotic Thrombocytopenic Purpura

Thrombotic Thrombocytopenic Purpura, Acquired

Abroad (travel likely)Recruiting

Milan, Italy

Longitudinal Cohort of Thrombosis and Hemostasis Diseases

Immune Thrombocytopenia · Thrombotic Thrombocytopenic Purpura · Hemophilia A, Acquired

Abroad (travel likely)Recruiting

Beijing, China · Beijing, China

Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)

Thrombotic Thrombocytopenic Purpura · Congenital Thrombotic Thrombocytopenic Purpura · Familial Thrombotic Thrombocytopenic Purpura

Abroad (travel likely)Recruiting

Oklahoma City, United States · Vienna, Austria